Libris Innovations is the for-profit subsidiary of the Indiana Biosciences Research Institute (IBRI), created to advance IBRI’s most promising scientific discoveries into new life sciences companies dedicated to delivering medical innovations for patients in need. Libris oversees the formation and growth of ventures originating from IBRI and partner innovation, providing strategic guidance and advisory support to help early-stage biotechnology companies attract the capital, talent, and resources needed to succeed. Companies supported by Libris benefit from strategic direction and operational support that help move discoveries from research through development and commercialization.